SN
Satyendra Naroni Singh
About Satyendra Naroni Singh
Data last updated:
Satyendra Naroni Singh is a Director at Eclipta Pharmaceutical Private Limited (since 2015). The company operates in Pharma. Eclipta Pharmaceutical Private Limited reported revenue of ₹1.96 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eclipta Pharmaceutical Private Limited U74900MP2015PTC035070 | Director | 10 Dec 2015 | 2015 | ₹1.96 Cr (FY 2025) | Active |
Board colleagues of Satyendra Naroni Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Neetu Singh | 07290913 | Eclipta Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyendra Naroni Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyendra Naroni Singh
Satyendra Naroni Singh currently holds 1 directorship: Eclipta Pharmaceutical Private Limited (Director, since 10 Dec 2015, revenue ₹1.96 Cr (FY 2025)).
Satyendra Naroni Singh was first appointed on 10 Dec 2015 as Director at Eclipta Pharmaceutical Private Limited.
The current boards of Satyendra Naroni Singh's companies include Neetu Singh (Eclipta Pharmaceutical Private Limited).